The Medicines Company to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013
Conference Call to Be Held at 8:30 a.m. Eastern Time

(firmenpresse) - PARSIPPANY, NJ -- (Marketwired) -- 04/11/13 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 24 at 8:30 a.m. Eastern Time to discuss first quarter 2013 financial results, operational developments, and outlook for 2013.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 877 474 9503
International Dial In: 857 244 7556
Passcode for both dial in numbers: 37313351
Replay is available from 10:30 a.m. Eastern Time following the conference call through May 8, 2013. To hear a replay of the call dial 888 286 8010 (domestic) and 617 801 6888 (international). Passcode for both dial in numbers is 12073390.
This call is being webcast and can be accessed via The Medicines Company website at .
The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .
Contact:
Michael Mitchell
The Medicines Company
973-290-6000
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 11.04.2013 - 16:09 Uhr
Sprache: Deutsch
News-ID 248302
Anzahl Zeichen: 0
contact information:
Town:
PARSIPPANY, NJ
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 190 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Medicines Company to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
The Medicines Company (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).